The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study.

This study showed an excess risk of SPMs in patients with early stage non-small cell lung cancer. We recommend a close follow-up, paying attention to concerning symptoms or examination findings and judicious use of age-appropriate cancer screening.